Health in EMR 66 indicators covering health for EMR. IndicatorLatest Year10-yr change Rank Total tetanus - number of reported cases 524 2025 down 40.8% 9th Pertussis - number of reported cases 14,992 2025 up 1,004.0% 11th Infant mortality rate (probability of dying between birth and age 1) 35.06 2024 down 20.9% 4th Under-five mortality rate 42.13 2024 down 21.0% 5th Maternal mortality ratio 167.38 2023 down 20.2% 4th Number of deaths among children ages 5 to 9 years 66,236 2024 down 1.7% 6th Mortality rate among children ages 5 to 9 years 3.61 2024 down 14.5% 5th Number of deaths among adolescents 52,267 2024 up 8.5% 9th Proportion of population with primary reliance on polluting fuels and 45.2% 2023 down 15.5% 3rd Population with primary reliance on polluting fuels and technologies 172.72 2023 down 3.5% 8th Population with primary reliance on clean fuels and technologies for 209.65 2023 up 34.5% 8th Proportion of population with primary reliance on fuels and 41.0% 2023 down 20.8% 4th Population with primary reliance on fuels and technologies for 153.85 2023 down 9.3% 6th Prevalence of diabetes, age-standardized 23.25 2022 up 28.4% 1st Prevalence of diabetes, crude 20.38 2022 up 39.7% 1st Diphtheria tetanus toxoid and pertussis first-dose (DTP1) 88.0% 2025 up 2.3% 9th Measles-containing-vaccine first-dose (MCV1) immunization coverage 81.0% 2025 up 1.2% 13th New HIV infections 0.1 2025 unchanged 5th BCG immunization coverage among 1-year-olds (%) 88.0% 2025 up 2.3% 9th Mean total cholesterol, crude 4.3 2018 down 2.3% 10th Mean HDL cholesterol, crude 1.1 2018 unchanged 10th Mean total cholesterol, age-standardized 4.3 2018 down 4.4% 10th Stunting prevalence among children under 5 years of age (%) 26.0% 2024 down 13.0% 7th Stunting numbers among children under 5 years of age (millions) 24,276 2024 down 9.8% 10th Overweight prevalence among children under 5 years of age (%) 4.5% 2024 down 31.8% 12th Overweight numbers among children under 5 years of age (thousands) 4,247 2024 down 28.6% 15th Adolescent mortality rate 2.66 2021 down 21.3% 4th Incidence of tuberculosis 112 2024 down 6.7% 10th Deaths due to tuberculosis among HIV-negative people 10 2024 down 23.1% 8th Domestic private health expenditure (PVT-D) as percentage of current 43.9% 2023 down 4.0% 4th Prevalence of HIV among adults aged 15 to 49 0.1% 2025 unchanged 12th Estimated number of people (all ages) living with HIV 610,000 2025 up 90.6% 12th Estimated antiretroviral therapy coverage among people living with HIV 31.0% 2025 up 121.4% 10th Hypertension: effective treatment coverage (controlled hypertension) 14.7% 2019 up 36.1% 10th Hypertension among adults aged 30-79 years, prevalence 37.8 2019 down 1.8% 1st Hypertension: diagnosis coverage among adults aged 30-79 with 46.6% 2019 up 11.8% 10th Hypertension treatment coverage among adults aged 30-79 with 36.2% 2019 up 10.0% 10th Hypertension: diagnosis coverage among adults aged 30-79 with 49.1% 2019 up 11.8% 10th Hypertension among adults aged 30-79 years, prevalence, crude 34.8 2019 down 0.9% 6th Number of new HIV infections 66,000 2025 up 88.6% 12th Births attended by skilled health personnel 87.0% 2025 up 20.8% 10th Inactivated first-dose polio vaccine (IPV1) immunization coverage 84.0% 2025 up 250.0% 13th Low birth weight number 2,949 2020 up 4.5% 10th Concentrations of fine particulate matter 40.5 2023 down 10.4% 4th Hepatitis B surface antigen (HBsAg) prevalence 0.5% 2024 down 16.7% 4th Number of deaths attributed to non-communicable diseases, by type of 431,312 2019 up 36.0% 15th Estimated number of MDR/RR-TB incident cases 19,000 2024 down 47.2% 10th Mean hemoglobin level of children aged 6-59 months 111 2019 up 1.8% 8th Number of children aged 6-59 months with anaemia 36,386 2019 up 6.8% 9th Prevalence of anaemia in children aged 6-59 months 42.7% 2019 down 8.2% 7th Estimated number of malaria cases 11.11 million 2024 up 179.4% 4th Number of reported cases of poliomyelitis by wild poliovirus 12 2023 down 63.6% 1st Estimated number of children needing antiretroviral therapy based on 20,000 2025 up 53.8% 10th Estimated antiretroviral therapy coverage among children 40 2025 up 150.0% 10th HPV immunization coverage estimates among primary target cohort (9-14) 17.0% 2025 — 10th Smear-positive tuberculosis treatment-success rate 88.0% 2011 up 7.3% 5th Number of indigenous P. falciparum malaria cases 1.51 million 2021 up 1,294.3% 4th Number of suspected malaria cases 20.46 million 2021 up 11.3% 6th Number of malaria positive cases by microscopy 1.53 million 2021 up 75.3% 4th Number of malaria suspects examined by microscopy 11.02 million 2021 down 1.9% 6th Page 1 of 2 Next →